Researchers Present a New Crystal Structure of Psilacetin, An Alternative Prodrug of Psilocin
Psilacetin is less expensive and easier to make than psilocybin.
Scientific Research - Page 23
FDA and NIH Weigh In On Psychedelics
FDA Commissioner, Dr. Scott Gottlieb and NIH Director, Dr. Francis Collins have responded to a letter from Sen. Brian Schatz requesting information about psychedelic drugs.
Psychedelics Can Help With Alcohol Use Disorder, Survey Results Suggest
Although studies show promising results, much of the chemistry and pharmacology of these compounds remains a mystery.
Positive Effects of Psilocybin Truffles Last For Seven Days, Study Finds
Enhancement of empathy, creative thinking, and subjective well-being outlasts the intoxication.
Single Inhalation of Dried Toad Secretions Provides Sub-Acute and Sustained Benefits
Increased mindfulness and decreased anxiety, depression, and stress were seen right away, becoming more significant four weeks after dosing.
Microdosing Data From the Analysis of YouTube Videos
Digital drug research offers insights into the little-understood world of microdosing psychedelics.
Imperial College’s Microdosing Survey Study
If you're planning on microdosing, participate in this study and be a part of scientific discovery.
The Importance of Set and Setting in Psychedelic Therapy
The context of the psychedelic experience plays a critical role in determining positive outcomes for patients.
The Crystal Structure of 4-AcO-DMT Fumarate
Herein, we report the solid state structure of 4-acetoxy-N,N-dimethyltryptamine fumarate.
Study Reveals the Crystal Structure of LSD Bound to the Human 5-HT2B Receptor
This structure reveals some reasons for the long-lasting effects of LSD and gives insight into the role of receptor signaling.